健保藥品HTA評估報告
| 序號 | 標題 | 檔案類型 |
|---|---|---|
| 51 | Rinvoq Extended-Release Tablets 15 mg |
|
| 52 | 百悅澤膠囊 (Brukinsa) |
|
| 53 | 修訂含SGLT-2 抑制劑與DPP-4 抑制劑複方製劑(如Steglujan、Glyxambi 及Qtern)藥品給付規定 |
|
| 54 | Bavencio 20mg/mL Concentrate for Solution for Infusion |
|
| 55 | Tonvasca |
|
| 56 | Tremsolin Tablets 50mg、250mg |
|
| 57 | 修訂血栓溶解劑含rt-PA 成分藥品(如Actilyse)之給付規定 |
|
| 58 | Lorviqua Film-Coated Tablets 25mg、100mg |
|
| 59 | Xtandi Soft Capsules |
|
| 60 | Evrysdi Powder for Oral Solution, 0.75 mg/ml |
|